Ads
related to: Fda and Therapeutics
Search results
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 2 days agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 2 days agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
InvestorPlace· 1 day agoBiotech stocks are not for the faint of heart. Between juggling FDA approvals, new product pipelines...
European Shares Rebound After Two Days Of Losses
RTT News· 59 minutes agoEuropean stocks were seeing modest gains on Thursday after two days of selling on inflation and interest-rate concerns. Unemployment across the eurozone has fallen to a new record low in April ...
Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
Zacks via Yahoo Finance· 7 days agoThe drugs are already approved for treating elevated LDL-C and CV risk reduction in the United...
American downgraded, United upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 21 hours agoCiti initiated coverage of Sage Therapeutics (SAGE) with a Sell rating and $8 price target. The...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Checkpoint Therapeutics ...
Akero Therapeutics, Inc. (AKRO) Investors: June 25, 2024 Filing Deadline in Securities Class Action...
Morningstar· 7 days ago(“Akero”) (NASDAQ: AKRO). As a result of Akero’s materially misleading statements and omissions to the public, Akero’s investors have suffered significant losses.
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 7 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic ...
Drug resistance discovery could 'move the field forward' for breast cancer treatment
Medical Xpress· 14 hours ago"Overcoming drug resistance is very important; we're talking about developing new drugs that will...